TRANS-3-BROMO-N-ETHYLCINNAMAMIDE
- CAS NO.:58473-74-8
- Empirical Formula: C11H12BrNO
- Molecular Weight: 254.12
- MDL number: MFCD00075351
- EINECS: 806-290-2
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-07 21:39:59
What is TRANS-3-BROMO-N-ETHYLCINNAMAMIDE?
Originator
Cinromide,ZYF Pharm Chemical
The Uses of TRANS-3-BROMO-N-ETHYLCINNAMAMIDE
bone resorption inhibitor, farnesyldiphosphate synthetase inhibitor, antimetastatic
The Uses of TRANS-3-BROMO-N-ETHYLCINNAMAMIDE
Cinromide is an anticonvulsant.
Definition
ChEBI: Cinromide is a member of cinnamamides and a secondary carboxamide.
Manufacturing Process
3-Bromo-N-ethylcinnamamide:
I). A solution of trans-3-bromocinnamoyl chloride (12.3 g) in anhydrous
toluene (150 ml) was added slowly with stirring to a solution of ethylamine
(10 g) in dry ether (100 ml) at room temperature. The reaction mixture was
heated at reflux for 1 hour, and the solvent and excess amine were then
removed under reduced pressure. The residue was triturated with water,
filtered, and recrystallized from ethanol-water to give trans-3-bromo-Nethylcinnamamide, m.p. 89-90°C, as a white crystalline material. NMR and IR
spectra as well as elemental analysis were consistent with the assigned
II). trans-m-Bromocinnamic acid (14.8 g), ethanol (173 ml) and concentrated
sulfuric acid (0.4 ml) were combined and heated at reflux for 15 hours. About
150 ml of the ethanol was distilled off, and the remaining solution was poured
into ice/water (140 ml). The cold mixture was made strongly alkaline with
40% sodium hydroxide and extracted with methylene chloride (4x60 ml). The
combined methylene chloride extract was dried over anhydrous potassium
carbonate. The potassium carbonate was removed by filtration and the solvent
stripped off under reduced pressure. trans-ethyl-3-Bromocinnamate, was
obtained as a partially solidified oil. (IR spectrum was consistent with this
compound).
trans-Ethyl-3-bromocinnamate (8.4 g), ethylamine (6.7 g), methanol (18 ml)
and 4A molecular sieves (1 g) were combined and heated at reflux for ? hour.
The mixture was cooled to about 45°C and sodium methylate (0.6 g) added.
The mixture was then heated at reflux 1? hour and then cooled. It was
acidified with concentrated hydrochloric acid (12 ml). The sieves were
removed by filtration. Ice water was added to the filtrate to precipitate trans
3-bromo-N-ethylcinnamamide, m.p. 89-90°C (after recrystallization from
ethanol/water)
Therapeutic Function
Anticonvulsant, Antiepileptic
Properties of TRANS-3-BROMO-N-ETHYLCINNAMAMIDE
Melting point: | 89-91 °C(lit.) |
Boiling point: | 417.5±45.0 °C(Predicted) |
Density | 1.369±0.06 g/cm3(Predicted) |
storage temp. | Sealed in dry,Room Temperature |
solubility | Chloroform (Slightly), Methanol (Slightly) |
form | Solid |
pka | 14.59±0.46(Predicted) |
color | Pale Beige |
Merck | 13,2334 |
Safety information for TRANS-3-BROMO-N-ETHYLCINNAMAMIDE
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for TRANS-3-BROMO-N-ETHYLCINNAMAMIDE
New Products
ALUMINIUM IODIDE 100 GM BUFFER CAPSULE PH 7.0 - 10 CAP BUFFER SOLUTION PH 9.5 (BORATE) EZEE BLUE GEL STAINER BORAX CARMINE (GRENACHERS ALCOHOLIC) POTASSIUM IODATE - IODIDE SOLN 0.1 N Dabigatran Acyl-O3-D-Glucuronide Trifluoroacetic Acid Salt Isofolic Acid Dabigatran 2-O-acylglucuronide metabolite Dabigatran Acyl-?-D- glucuronide Trifluroacetic Acid Erythromycin EP Impurity A Desloratidine Related Compound ARelated products of tetrahydrofuran
You may like
-
Dabigatran Acyl-O2-D-Glucuronide Trifluoroacetic Acid SaltView Details
-
Dechloro DesloratadineView Details
-
Dehydro DesloratadineView Details
-
Edoxaban Impurity 57View Details
2089454-69-1 -
Eltrombopag N-Oxide ImpurityView Details
2734533-17-4 -
Empagliflozin Bromo ImpurityView Details
-
Glycopyrronium Bromide EP Impurity IView Details
1404617-94-2 -
Ipratropium EP Impurity BView Details
58073-59-9